According to the results mentioned above, the single CHRNB4 can become a novel, reliable, and independent prognostic marker for better management of ESCC, with sufficient predictive ability, stronger than the traditional TNM-based model. This evidence concerns the gene CHRNB4 and esophageal squamous cell carcinoma.